Bill Snyder
-
Competition showcases commercial viability of ideas
A strategy for commercializing an optical 3-D scanner that can ensure all cancerous breast tissue is removed during surgery, thereby avoiding the need for a second operation, has won top honors at this year’s TechVenture Challenge. Read MoreApr 17, 2014
-
Channel drug restores glucose balance
A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis. Read MoreApr 16, 2014
-
Discovery Lecture to feature two pioneers in dyslexia care, research
Sally Shaywitz, M.D., and Bennett Shaywitz, M.D., co-directors of the Yale Center for Dyslexia & Creativity, will deliver the next Flexner Discovery Lecture on Thursday, April 17. Read MoreApr 10, 2014
-
Study tracks new lung cancer drug target
Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat. Read MoreApr 10, 2014
-
Gut woes of preemies focus of microbiome effort
A multidisciplinary team of microbiome researchers at Vanderbilt University is shedding light on necrotizing enterocolitis (NEC), a disease of prematurity that kills hundreds of babies and costs the U.S. health care system an estimated $5 billion a year. Read MoreMar 27, 2014
-
Health Professions Graduate School Fair set for April 3
The eighth annual Health Professions Graduate School Fair will be held from 2-6 p.m. Thursday, April 3, at the Vanderbilt Student Life Center. Read MoreMar 27, 2014
-
New system helps speed transfer of research materials
Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research. Read MoreMar 20, 2014
-
Infection research symposium set for April 11
The latest research on pneumonic plague, respiratory syncytial virus (RSV) and other life-threatening infections will be discussed during a Symposium on Infection and Immunity April 11 at the Vanderbilt Student Life Center. Read MoreMar 20, 2014
-
Small molecule protects kidney filter
A compound identified at Vanderbilt has therapeutic potential in protecting the kidney filter barrier. Read MoreMar 19, 2014
-
‘Missing link’ may spur new brain disorder drugs
Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease. Read MoreMar 13, 2014
-
Viral illness may spur ‘standing up’ disorder
Circulating “autoantibodies” possibly triggered by a viral illness may contribute an abnormally rapid heart rate or tachycardia upon standing that affects 500,000 Americans, mostly young women, according to researchers at the University of Oklahoma and Vanderbilt University. Read MoreMar 13, 2014
-
Biomedical engineering institute honors four faculty
Four Vanderbilt University faculty members have been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Read MoreMar 13, 2014
-
Pharmacology forum set for March 18
“Safety Pharmacology” will be the topic of the 23rd annual Joel G. Hardman Student-Invited Pharmacology Forum Tuesday, March 18, in 202 Light Hall. Read MoreMar 13, 2014
-
Diabetes researchers track cells’ ability to regenerate
Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate. Read MoreMar 13, 2014
-
Multi-center effort targets lethal Ebola, Marburg viruses
Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections. Read MoreMar 6, 2014
-
Mission focus key to meeting health care challenges: Balser
“There has never been a time when we need leaders more than today.” With these words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, began his quarterly conversation with colleagues at Wednesday’s Clinical Enterprise Leadership Assembly in Langford Auditorium. Read MoreMar 6, 2014
-
Discovery sheds new light on marijuana’s anxiety relief effects
An international group led by Vanderbilt University researchers has found cannabinoid receptors, through which marijuana exerts its effects, in a key emotional hub in the brain involved in regulating anxiety and the flight-or-fight response. Read MoreMar 6, 2014
-
Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells
Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years. Read MoreMar 3, 2014
-
ASPET honors Lindsley’s pharmacology research
Vanderbilt University’s Craig Lindsley, Ph.D., has won the 2014 John J. Abel Award in Pharmacology for young investigators from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read MoreFeb 27, 2014
-
Event set to reveal wonders, mysteries of the brain
“Brain Blast,” a half day of free, hands-on activities for children and adults, will be held from 9 a.m. to 1 p.m., Saturday, March 1, at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane. Read MoreFeb 20, 2014